Long-term Efficacy and Safety of Lamivudine, Entecavir, and Tenofovir for Treatment of Hepatitis B Virus–Related Cirrhosis
Authors:
- Seyfettin KöklüSKSeyfettin Köklü
- Yaşar TunaYTYaşar Tuna
- Murat Taner GülşenMGMurat Taner Gülşen
- Mehmet DemirMDMehmet Demir
- Aydin Şeref KöksalAKAydin Şeref Köksal
- Muhammet Cem KoçkarMKMuhammet Cem Koçkar
- Cem AygünCACem Aygün
- Şahin ÇobanŞÇŞahin Çoban
- Kamil ÖzdilKÖKamil Özdil
- Hüseyin AtasevenHAHüseyin Ataseven
- Ebru AkinEAEbru Akin
- Tuğrul PürnakTPTuğrul Pürnak
- 1 January 2013
- journal article
- research article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 11 (1) , 88-94
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Management of chronic hepatitis BEuropean Journal of Gastroenterology & Hepatology, 2011
- Treatment of Hepatitis B in Decompensated Liver CirrhosisInternational Journal of Hepatology, 2011
- Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver diseaseHepatology, 2010
- 7 TREATMENT OF DECOMPENSATED HBV-CIRRHOSIS: RESULTS FROM 2-YEARS RANDOMIZED TRIAL WITH TELBIVUDINE OR LAMIVUDINEJournal of Hepatology, 2010
- Efficacy of entecavir in treatment-naïve patients with hepatitis B virus-related decompensated cirrhosisJournal of Hepatology, 2010
- Adefovir Dipivoxil for Wait-Listed and Post–Liver Transplantation Patients with Lamivudine-Resistant Hepatitis BLiver Transplantation, 2007
- Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver DiseaseNew England Journal of Medicine, 2004
- Determinants of early mortality in patients with decompensated chronic hepatitis B treated with antiviral therapyGastroenterology, 2002
- Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infectionJournal of Hepatology, 2000
- Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liverGastroenterology, 1992